Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Sanofi SA    SNY   US80105N1054

SANOFI SA (SNY)

9
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi SA
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following segments: Pharmaceuticals, Human Vaccines, Animal Health, and Others.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for a wide variety of animal species.

The Others segment includes all activities that do not qualify as reportable segments under IFRS 8 “Operating Segments”; it also includes the effects of retained commitments in respect of divested businesses.

The company was founded in 1994 and is headquartered in Paris, France.

Number of employees : 113 496 persons.
Sales per Businesses
20132014Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals36,24782.7%36,62882.1% +1.04%
Vaccines4,94311.3%5,25111.8% +5.87%
Animal Health2,6406%2,7436.1% +3.74%
Other-----
Sales per Regions
20132014Delta
USD (in Million)%USD (in Million)%
Other Countries15,21934.7%15,13333.9% -0.56%
United States13,87831.7%14,98333.6% +7.38%
Europe10,55224.1%10,48123.5% -0.68%
France3,4207.8%3,2697.3% -4.62%
North America762.191.7%755.811.7% -0.84%
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD592015Chief Executive Officer
Serge Weinberg642009Chairman
Jérôme Contamine582009Chief Financial Officer & EVP-Finance
Elias E. Zerhouni, MD642011President-Global Research & Development
Igor Landau712004Director
Robert Castaigne, PhD622000Independent Director
Jean-René Fourtou762004Independent Director
Claudie Haigneré MD, PhD582008Independent Director
Uwe Bicker PhD, MD702008Independent Director
Gérard van Kemmel, MBA762003Independent Director
Shareholders
NameShares%
Dodge & Cox 43,272,800 1.64%
Barrow, Hanley, Mewhinney & Strauss LLC 30,804,459 1.17%
Franklin Advisers, Inc. 18,836,579 0.71%
Fisher Asset Management LLC 13,085,033 0.50%
Neuberger Berman LLC 11,897,437 0.45%
Hotchkis & Wiley Capital Management LLC 11,692,693 0.44%
Fidelity Management & Research Co. 10,631,734 0.40%
Invesco Advisers, Inc. 9,195,182 0.35%
Harris Associates LP 5,895,950 0.22%
PRIMECAP Management Co. 4,287,207 0.16%
Holdings
NameShares%Valuation
Regeneron Pharmaceuticals Inc (REGN) 22,859,14422.7%10,320,446,333 USD
Sanofi (SAN) 12,190,8390.92%1,203,635,913 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,051,60312.0%1,049,588,385 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%745,697,271 USD
Sanofi India Ltd (SANOFI) 13,909,58760.4%745,697,271 USD
Zentiva SA (ROSCD) 312,341,64974.9%130,708,733 USD
Nichi-iko Pharmaceutical Co., Ltd. (4541) 2,846,0004.69%65,688,782 USD
Immune Design Corp (IMDZ) 917,4295.44%19,366,926 USD
GlycoMimetics Inc (GLYC) 1,084,2055.71%9,020,586 USD
Proteome Sciences plc (PRM) 46,0000.021%14,084 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
NOVARTIS AG
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
PFIZER INC.
MERCK & CO., INC.
SANOFI
BAYER AG
ACTAVIS PLC
NOVO NORDISK A/S
GLAXOSMITHKLINE P..
BRISTOL-MYERS SQU..
ELI LILLY AND CO
ABBOTT LABORATORI..
VALEANT PHARMACEU..
TEVA PHARMACEUTIC..
SHIRE PLC
REGENERON PHARMAC..
TAKEDA PHARMACEUT..
MYLAN NV
ASTELLAS PHARMA I..
Sector Pharmaceuticals
Sanofi SA : Connections
VL Holding (France)
Alliance Automotive Group SAS
Financière BFSA
Piasa Holding
Fondation C.Génial
Institute of Medicine
Sanofi-Aventis Europe SAS
INSEAD
Sanofi Aventis Participations SA
Financière Piasa
The Children's Aid Society, Inc.
Piasa SA
Financières SASA
National Academy of Engineering
Sanofi Pasteur Holding SA
The Johns Hopkins University
Sanofi-Aventis U.S. LLC
Montres CORUM Sàrl
École Normale Supérieure
Bordeaux University Foundation
Universcience.fr
Weinberg Capital Partners SAS
Pres héSam
Academie des Sports
Académie des Sciences et Technologies
Fondation de France
Aventis Foundation
L'Oréal Corporate Foundation
Mayo Clinic
Fondations René Lacoste
Lasker Foundation
Académie des Technologies
Research!America
Academie de l'air et de l'espace
King Abdullah University of Science & Technology
Philipps University of Marburg
Académie Nationale de Médecine
Ruprecht-Karls-Universität Heidelberg
Company contact information
Sanofi
54, rue La Boétie
Paris, Ile-de-France 75008

Phone : +33.1.53.77.40.00
Fax : +33.1.53.77.44.63
Web : www.sanofi.com
© 2015 People , Fundamentals and Ownership   
Dynamic quotes  
ON
| OFF